Remus Pharmaceuticals Limited (NSE:REMUS)
India flag India · Delayed Price · Currency is INR
878.55
-11.25 (-1.26%)
At close: Jul 10, 2025

Remus Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
10,96713,19210,163---
Upgrade
Market Cap Growth
29.81%29.81%----
Upgrade
Enterprise Value
11,38313,16410,212---
Upgrade
Last Close Price
930.701119.47861.57---
Upgrade
PE Ratio
28.5445.3847.19---
Upgrade
PS Ratio
1.772.134.77---
Upgrade
PB Ratio
3.884.679.74---
Upgrade
P/TBV Ratio
4.445.3413.11---
Upgrade
P/FCF Ratio
--342.57---
Upgrade
P/OCF Ratio
157.13189.00282.11---
Upgrade
EV/Sales Ratio
1.832.124.80---
Upgrade
EV/EBITDA Ratio
24.9128.8135.41---
Upgrade
EV/EBIT Ratio
25.9830.0436.52---
Upgrade
EV/FCF Ratio
-274.94-344.23---
Upgrade
Debt / Equity Ratio
0.080.080.110.420.030.09
Upgrade
Debt / EBITDA Ratio
0.500.500.400.710.040.21
Upgrade
Debt / FCF Ratio
--3.893.080.040.10
Upgrade
Asset Turnover
1.801.801.461.791.842.30
Upgrade
Inventory Turnover
11.2911.297.6222.888.9614.50
Upgrade
Quick Ratio
0.960.960.960.970.440.58
Upgrade
Current Ratio
1.821.821.401.390.840.98
Upgrade
Return on Equity (ROE)
19.86%19.86%42.08%66.14%71.37%40.49%
Upgrade
Return on Assets (ROA)
7.94%7.94%11.97%26.40%19.63%8.89%
Upgrade
Return on Capital (ROIC)
13.00%13.00%24.45%39.41%52.34%25.48%
Upgrade
Return on Capital Employed (ROCE)
14.10%14.10%25.90%40.30%63.30%34.60%
Upgrade
Earnings Yield
2.65%2.20%2.12%---
Upgrade
FCF Yield
-0.38%-0.31%0.29%---
Upgrade
Dividend Yield
0.09%0.07%0.09%---
Upgrade
Payout Ratio
4.06%4.06%2.74%---
Upgrade
Buyback Yield / Dilution
21.35%21.35%-38.79%-2.10%--
Upgrade
Total Shareholder Return
21.43%21.42%-38.70%-2.10%--
Upgrade
Updated Nov 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.